Emily Smith
Impact in
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- Psoriasis: Treatment and Pathogenesis
- Immune cells in cancer
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunology and Allergy top 5%
Papers in
-
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 3
- Immunology 12
- Immune Response and Inflammation 5
- Psoriasis: Treatment and Pathogenesis 4
- Immune cells in cancer 3
- Co-authors
- Klaus Ley (6 shared papers)Matthew A. Stark (4 shared papers)Elena Galkina (1 shared paper)Matthew Butcher (1 shared paper)Jay K. Kolls (1 shared paper)Anca D. Dobrian (1 shared paper)Konkal-Matt R Prasad (1 shared paper)Gerard B. Nash (7 shared papers)
- Journals
- The Journal of Immunology (4 papers)Blood (3 papers)The FASEB Journal (1 paper)Journal of Cellular Biochemistry (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
Emily Smith
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 95
- Immunology 756
- Immunology and Allergy 92
- Oncology 327
- Rheumatology 149
- Hematology 113
Countries citing papers authored by Emily Smith
This map shows the geographic impact of Emily Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Smith more than expected).
Fields of papers citing papers by Emily Smith
This network shows the impact of papers produced by Emily Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Smith. The network helps show where Emily Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 346 | |
| 2 | 2005 | 194 | |
| 3 | 2006 | 128 | |
| 4 | 2019 | 121 | |
| 5 | 2005 | 97 | |
| 6 | 2008 | 90 | |
| 7 | 2006 | 80 | |
| 8 | 2007 | 78 | |
| 9 | 2009 | 76 | |
| 10 | 2013 | 64 | |
| 11 | 2008 | 48 | |
| 12 | 2009 | 47 | |
| 13 | 2001 | 43 | |
| 14 | 2008 | 42 | |
| 15 | 2015 | 36 | |
| 16 | 2016 | 31 | |
| 17 | 2013 | 28 | |
| 18 | 2002 | 28 | |
| 19 | Suppression of normal human hematopoiesis by cytomegalovirus in vitro. | 1993 | 27 |
| 20 | 2004 | 23 |
About Emily Smith
Emily Smith is a scholar working on Molecular Biology, Immunology, Oncology, Hematology and Pathology and Forensic Medicine, having authored 37 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immune Response and Inflammation (5 papers), Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Cancer Cells and Metastasis (3 papers), Immune cells in cancer (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Immunology (756 citations), Immunology and Allergy (92 citations), Oncology (327 citations), Rheumatology (149 citations) and Hematology (113 citations). Emily Smith has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Klaus Ley, Matthew A. Stark, Elena Galkina, Matthew Butcher, Jay K. Kolls, Anca D. Dobrian, Konkal-Matt R Prasad, Gerard B. Nash, Christopher D. Buckley and G. Ed Rainger. Their work appears in journals such as The Journal of Immunology, Blood, The FASEB Journal, Journal of Cellular Biochemistry and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.